References
- Binti N, Razak A, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers 2018;10(10):380. doi:https://doi.org/10.3390/cancers10100380
- Sheth RA, Niekamp A, Quencer KB, Shamoun F, Knuttinen MG, Naidu S, Okl R. Thrombosis in cancer patients: etiology, incidence, and management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S178–S185. doi:https://doi.org/10.21037/cdt.2017.11.02
- Mandalà M, Falanga A, Roila F, ESMO Guidelines Working Group. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(Suppl 6):vi85–vi92. doi:https://doi.org/10.1093/annonc/mdr392
- Sharma D, Kannan R, Tapkire R, Nath S. Evaluation of nutritional status of cancer patients during treatment by patient-generated subjective global assessment: A hospital-based study. Asian Pac J Cancer Prev. 2015; 16 (18):8173–8176. doi:https://doi.org/10.7314/apjcp.2015.16.18.8173
- Mantovani G. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia. Eur Rev Med Pharmacol Sci. 2010;14(4):292–301.
- Madeddu C, Macciò A, Panzone F, Tanca FM, Mantovani G. Medroxyprogesterone acetate in the management of cancer cachexia. Expert Opin Pharmacother. 2009;10(8):1359–1366. doi:https://doi.org/10.1517/14656560902960162
- Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437–444. doi:https://doi.org/10.1097/MOH.0b013e3283634443
- Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162–168. doi:https://doi.org/10.15386/mpr-1372
- Rolland-Cachera MF, Brambilla P, Manzoni P, Akrout M, Sironi S, Del Maschio A, Chiumello G. Body composition assessed on the basis of arm circumference and triceps skinfold thickness: A new index validated in children by magnetic resonance imaging. Am J Clin Nutr. 1997;65(6):1709–13. doi:https://doi.org/10.1093/ajcn/65.6.1709 PMID: 9174464.
- Siminkovitch S, Vladimirov B. 2017. Prealbumin and retinol binding protein as screening tools for malnutrition. In: Preedy V, Patel V, editors. Handbook of famine, starvation, and nutrient deprivation. Cham: Springer. https://doi.org/10.1007/978-3-319-40007-5_54-1.
- Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? 1987. Classical article. Nutr Hosp. 2008;23(4):400–407.
- Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR, van Es N, CAT-prediction orators. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 2019;104(6):1277–1287. doi:https://doi.org/10.3324/haematol.2018.209114
- Allman-Farinelli MA. Obesity and venous thrombosis: A review. Semin Thromb Hemost. 2011;37(8):903–907. doi:https://doi.org/10.1055/s-0031-1297369 PMID: 22198855.
- Borch KH, Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen J-B. Anthropometric measures of obesity and risk of venous thromboembolism: The Tromso study. Arterioscler Thromb Vasc Biol. 2010;30(1):121–127. doi:https://doi.org/10.1161/ATVBAHA.109.188920
- Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: The study of men born in 1913. Arch Intern Med. 1999;159(16):1886–1890. doi:https://doi.org/10.1001/archinte.159.16.1886
- Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62–69. doi:https://doi.org/10.1053/j.seminhematol.2007.02.004
- Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001275. doi:https://doi.org/10.1371/journal.pmed.1001275
- Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res. 2006;118(5):555–568. doi:https://doi.org/10.1016/j.thromres.2005.10.015
- Connolly G, Francis CW. Cancer-associated thrombosis. Hematol ASH Educ Prog. 2013, 2013; :684–691.
- Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sørensen HT. Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006. Br J Cancer 2010;103(7):947–953. doi:https://doi.org/10.1038/sj.bjc.6605883
- Blom JW, Doggen CM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293(6):715–722. doi:https://doi.org/10.1001/jama.293.6.715
- Fuentes HE, Tafur AJ, Caprini JA. Cancer-associated thrombosis. Dis Mon. 2016;62(5):121–158. doi:https://doi.org/10.1016/j.disamonth.2016.03.003
- Levi M. Management of cancer-associated disseminated intravascular coagulation. Thromb Res. 2016; 140:S66–S70. doi:https://doi.org/10.1016/S0049-3848(16)30101-3
- Hayıroğlu Mİ, Keskin M, Keskin T, Uzun AO, Altay S, Kaya A, Öz A, Çinier G, Güvenç TS, Kozan Ö. A novel independent survival predictor in pulmonary embolism: Prognostic nutritional index. Clin Appl Thromb Hemost. 2018;24(4):633–639. doi:https://doi.org/10.1177/1076029617703482 Epub 2017 Apr 12. PMID: 28401800; PMCID: PMC6714701.